FDA approves new Covid-19 vaccines in US but limits who can get them

The FDA has authorized updated Covid-19 vaccines in the US, but with new restrictions on who can receive them. The vaccines are now approved for individuals aged 65 and older, as they are more vulnerable to severe Covid-19 illness. Younger people may also be eligible if they have underlying medical conditions that increase their risk. The decision aims to prioritize the distribution of the limited vaccine supplies to those most at risk of experiencing serious health consequences from Covid-19. While the new vaccines offer improved protection, the FDA has deemed it necessary to focus on the elderly and high-risk populations in the initial phase of the rollout. The article highlights the FDA's efforts to balance the availability of the updated vaccines with the need to protect the most vulnerable members of the population. This targeted approach reflects the ongoing challenges in managing the Covid-19 pandemic and the importance of tailoring public health measures to address the specific needs of different demographic groups.